Trials / Sponsors / Mereo BioPharma

Mereo BioPharma

Industry · 12 registered clinical trials.

Status	Trial	Phase	Started
Completed	A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor	Phase 1 / Phase 2	2021-03-23
Completed	A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Pla Alpha 1-Antitrypsin Deficiency, Emphysema, COPD	Phase 2	2018-10-29
Completed	The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants Interaction	Phase 1	2018-03-19
Completed	A 6 Month Safety Extension Study of MBGS205 Hypogonadotropic Hypogonadism	Phase 2	2016-11-15
Completed	The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers Interaction	Phase 1	2016-09-01
Completed	Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonar Pulmonary Disease, Chronic Obstructive	Phase 2	2016-08-01
Completed	Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism Hypogonadotropic Hypogonadism	Phase 2	2016-05-12
Terminated	Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery Acute Kidney Injury	Phase 2	2011-09-01
Completed	Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation Chronic Obstructive Pulmonary Disease	Phase 2	2011-03-01
Terminated	Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men Obese Hypogonadotropic Hypogonadism	Phase 2	2010-08-01
Completed	BGS649 Monotherapy in Moderate to Severe Endometriosis Patients Endometriosis	Phase 2	2010-07-01
Terminated	A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis Pelvic Pain Associated With Refractory Endometriosis	Phase 2	2010-04-15